Background: Amyotrophic lateral sclerosis (ALS) is a progressive neuromuscular disorder
that is inevitably fatal. There are no effective treatments to stop or reverse the natural course …

Background Despite being one of the most devastating diseases known, there is little
evidence for diagnosing and managing patients with amyotrophic lateral sclerosis (ALS) …

Amyotrophic lateral sclerosis (ALS) is a rapidly progressive motor neuron disease that poses
a myriad of clinical problems Patients with ALS are best treated in a multidisciplinary setting …

Amyotrophic lateral sclerosis (ALS), first described by Jean-Martin Charcot in the 1870s, is
an age-related disorder that leads to degeneration of motor neurons. The disease begins …

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease affecting the motor
nervous system. It causes progressive and cumulative physical disabilities in patients, and …

The main aims in the care of individuals with amyotrophic lateral sclerosis (ALS) are to
minimize morbidity and maximize quality of life. Although no cure exists for ALS, supportive …

The variable clinical course of Amyotrophic Lateral Sclerosis (ALS) confronts the clinician,
the patient and caregivers with many ethical challenges from the moment of breaking the …

Amyotrophic lateral sclerosis (ALS) is a devastating, progressive motor neuron disorder that
poses a myriad of clinical problems. Patients who have ALS are best cared for in a …

Amyotrophic lateral sclerosis (ALS) is a relentlessly progressive and fatal
neurodegenerative disease characterized by progressive weakness of voluntary muscles of …

Patients with amyotrophic lateral sclerosis (ALS) have high symptom burdens, including
pain, fatigue, dyspnea, and sialorrhea, and they must make difficult decisions about the use …